Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (21)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Horiuchi, A.
Right arrow Articles by Fujii, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Horiuchi, A.
Right arrow Articles by Fujii, S.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Molecular Human Reproduction, Vol. 6, No. 6, 523-528, June 2000
© 2000 European Society of Human Reproduction and Embryology


Uterine physiology

HCG promotes proliferation of uterine leiomyomal cells more strongly than that of myometrial smooth muscle cells in vitro

Akiko Horiuchi1, Toshio Nikaido1,3, Toru Yoshizawa1, Kazuko Itoh1, Yaeko Kobayashi1, Toshihiko Toki1, Ikuo Konishi1 and Shingo Fujii2

1 Department of Obstetrics and Gynecology, Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto 390-8621, and 2 Department of Gynecology and Obstetrics, Faculty of Medicine, Kyoto University, Sakyo-ku, Kyoto 606-8507, Japan

Abstract

Uterine myomas often enlarge rapidly during pregnancy. This rapid increase in size may imply that human chorionic gonadotrophin (HCG) influences cell proliferation in uterine leiomyomata. To assess the direct effect of HCG on normal uterine smooth muscle and uterine leiomyomata, we investigated cell proliferation and the expression of cell cycle-related proteins in these cells. Reverse transcription–polymerase chain reaction (RT–PCR) analysis revealed that HCG/LH receptor was present in both cultured myometrial and leiomyomal cells. Treatment with HCG significantly increased cell proliferation in both myometrial and leiomyomal cells (P < 0.03), especially at an early phase in the 9 day culture. The increase in the viable cell number induced by HCG treatment was significantly greater in leiomyoma cells than in myometrial cells on day 3 in culture (P < 0.03). In leiomyomal cells, the expression of proliferating cell nuclear antigen (PCNA), cyclin E and cdc2 was significantly increased by HCG treatment (P < 0.05) even at the lowest concentration used (3 nmol/l). In myometrial cells, the expression of cyclin E and cdc2 was significantly increased by HCG treatment (P < 0.05) only at the highest concentration used (30 nmol/l). These results suggest that HCG directly promotes the proliferation of myometrial and leiomyomal cells, with the latter showing the greater response of the two.

cell proliferation/HCG/HCG/LH receptor/leiomyoma/uterus

Notes

3 To whom correspondence should be addressed at: Department of Obstetrics and Gynecology, Shinshu University School of Medicine, 30-1-1 Asahi, Matsumoto 390-8621, Japan. E-mail: tnikaido{at}hsp.md.shinshu-u.ac.jp


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
EndocrinologyHome page
J. Prast, L. Saleh, H. Husslein, S. Sonderegger, H. Helmer, and M. Knofler
Human Chorionic Gonadotropin Stimulates Trophoblast Invasion through Extracellularly Regulated Kinase and AKT Signaling
Endocrinology, March 1, 2008; 149(3): 979 - 987.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
E. Dos Santos, M.-N. Dieudonne, M.-C. Leneveu, R. Pecquery, V. Serazin, and Y. Giudicelli
In vitro effects of chorionic gonadotropin hormone on human adipose development
J. Endocrinol., August 1, 2007; 194(2): 313 - 325.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
A.V. Huber, L. Saleh, J. Prast, P. Haslinger, and M. Knofler
Human chorionic gonadotrophin attenuates NF-{kappa}B activation and cytokine expression of endometriotic stromal cells
Mol. Hum. Reprod., August 1, 2007; 13(8): 595 - 604.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
D. Grisaru, R. Keidar, L. Schreiber, J. B. Lessing, and V. Deutsch
The effect of the readthrough acetylcholinesterase variant (AChE-R) on uterine muscle and leiomyomas
Mol. Hum. Reprod., May 1, 2007; 13(5): 351 - 354.
[Abstract] [Full Text] [PDF]


Home page
Reproductive SciencesHome page
C. V. Rao
Physiological and Pathological Relevance of Human Uterine LH/hCG Receptors
Reproductive Sciences, February 1, 2006; 13(2): 77 - 78.
[PDF]


Home page
Reproductive SciencesHome page
D. D. Baird, J. S. Kesner, and D. B. Dunson
Luteinizing Hormone in Premenopausal Women May Stimulate Uterine Leiomyomata Development
Reproductive Sciences, February 1, 2006; 13(2): 130 - 135.
[Abstract] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
P. C. Lin, X. Li, Z. M. Lei, and Ch. V. Rao
Human Cervix Contains Functional Luteinizing Hormone/Human Chorionic Gonadotropin Receptors
J. Clin. Endocrinol. Metab., July 1, 2003; 88(7): 3409 - 3414.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
K. A. Kovacs, A. Oszter, P. M. Gocze, J. L. Kornyei, and I. Szabo
Comparative analysis of cyclin D1 and oestrogen receptor ({alpha} and {beta}) levels in human leiomyoma and adjacent myometrium
Mol. Hum. Reprod., November 1, 2001; 7(11): 1085 - 1091.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
O. Kurachi, H. Matsuo, T. Samoto, and T. Maruo
Tumor Necrosis Factor-{{alpha}} Expression in Human Uterine Leiomyoma and Its Down-Regulation by Progesterone
J. Clin. Endocrinol. Metab., May 1, 2001; 86(5): 2275 - 2280.
[Abstract] [Full Text]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.